Exscientia Ltd ADR Financials

Exscientia Stock Summary

Exscientia competes with Zura Bio, Elevation Oncology, Recursion Pharmaceuticals, Atea Pharmaceuticals, and Unity Biotechnology. Exscientia plc, an artificial intelligence-driven pharmatech company, engages in discovering, designing, and developing drugs. The company was founded in 2012 and is headquartered in Oxford, the United Kingdom. Exscientia operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 285 people.

Exscientia Key Financial Ratios

Exscientia Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Exscientia's current stock value. Our valuation model uses many indicators to compare Exscientia value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Exscientia competition to find correlations between indicators driving Exscientia's intrinsic value. More Info.Exscientia Ltd ADR is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Exscientia's earnings, one of the primary drivers of an investment's value.

Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.

If you are still planning to invest in Exscientia ADR check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Exscientia's history and understand the potential risks before investing.